author-photo

Leonid Dubrovsky

Memorial Sloan Kettering Cancer Center

14

Papers

242

Citations

Citation Trend

Filter By

Papers (10) Sort By

Journal Conference Others

Therapeutic superiority of a TCR-like antibody to an intracellular WT1 oncogene peptide compared with the tyrosine kinase inhibitor imatinib in a mouse model of Philadelphia chromosome positive (Ph+) ALL.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens

2017 Journal of Clinical Investigation
Show All
- Source
- Cite
- Save
Citations (42)
Abstract A055: Potent therapeutic and immunological effects of the first T-BiTE derived from a TCR-mimic antibody targeting intracellular oncoprotein WT1

2016 Cancer immunology research
Show All
- Source
- Cite
- Save
Citations (0)
T cell receptor mimic antibodies for cancer therapy

2016 OncoImmunology
Show All
- Source
- Cite
- Save
Citations (24)
Mechanisms of leukemia resistance to antibody dependent cellular cytotoxicity

2016 OncoImmunology
Show All
- Source
- Cite
- Save
Citations (2)
Therapeutic activity of a bi-specific T cell engaging, TCR-mimic monoclonal antibody to WT1 against human leukemias and cancers in mouse models

2015 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1.

2015 Nature Biotechnology
Show All
- Source
- Cite
- Save
Citations (88)
TherapeuticEfficacyofanFc-EnhancedTCR-likeAntibodyto the Intracellular WT1 Oncoprotein

2014
Show All
- Source
- Cite
- Save
Citations (0)
Therapeutic Efficacy of an Fc-Enhanced TCR-like Antibody to the Intracellular WT1 Oncoprotein

2014 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (35)
leukemias + resistance in human BCR-ABL A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor

2014
Show All
- Source
- Cite
- Save
Citations (1)